Our Research Let’s take a look.

On his website, Dan Wesson, Ph.D., says, “Here in the Wesson Lab, we explore the neural processing of sensory information in the context of behavior. ”

The Bird Lab is interested in how myosin molecular motors generate force on actin filaments and how defects in this fundamental cytoskeletal mechanism cause human disease. Dr. Bird studies this question using hair cells, the neural receptors for hearing and balance that are found within the inner ear.

Meet Olga Guryanova, M.D., Ph.D., assistant professor, and learn about her research on chromatin organization and epigenetic regulation on leukemia development.

As stated on his website, Daniel Kopinke’s lab deals with defects in primary cilia can result in a wide range of diseases, referred to as “ciliopathies.”

Efforts in Dr. Harrison’s laboratory are directed toward understanding mechanisms by which immune cells contribute to tumor progression and resistance to immunotherapies. 

The Hammers Lab researches physiological and pathophysiological mechanisms of skeletal and cardiac muscle, particularly those associated with genetic diseases known as muscular dystrophies. The primary motivation of these efforts is to identify potential therapeutic targets that can be exploited to develop treatments for muscle and heart diseases using small molecules and/or adeno-associated virus (AAV)-based gene therapies.

The Law Lab researches mechanisms by which CDCP1 Promotes Breast Cancer Metastasis: The CDCP1 protein functions as a scaffold to bring together and facilitate synergy between the oncoproteins Epidermal Growth Factor Receptor (EGFR) and the Src tyrosine kinase. 

The Moehle Lab is interested in understanding the physiological, circuitry, and behavioral changes that cause the motor and non-motor symptoms of movement disorders and then translate these findings into novel therapeutics for these disorders.

Steve Munger’s lab researches: mechanisms of alimentary chemosensation, extraoral chemoreceptors and the regulation of metabolism and olfactory detection of social cues.

Roger Papke says on his website, “We seek to revitalize these spirits and with our accumulating understanding of cellular function and disease identify specific ion channels and neurotransmitter receptors as therapeutic targets.”

 The goals of our lab are to identify and map neuronal circuits that regulate dopamine signaling, motivation, movement and reward, by using state of the art tools such as viral tracing, opto/chemogenetics, fiber photometry, and operant behavioral conditioning.

Much of the Sweeney Lab’s research program is translational in focus, and has produced highly cited research on inherited forms of cardiovascular disease, and on the skeletal and cardiac aspects of muscular dystrophy. Currently the lab is focused on AAV gene therapy for animal models of Duchenne muscular dystrophy and small molecule therapies to augment the gene therapy.